277 related articles for article (PubMed ID: 32513989)
21. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.
Wang F; Nie J; Wang H; Zhao Q; Xiong Y; Deng L; Song S; Ma Z; Mo P; Zhang Y
J Infect Dis; 2020 May; 221(11):1762-1769. PubMed ID: 32227123
[TBL] [Abstract][Full Text] [Related]
22. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients.
Wan S; Yi Q; Fan S; Lv J; Zhang X; Guo L; Lang C; Xiao Q; Xiao K; Yi Z; Qiang M; Xiang J; Zhang B; Chen Y; Gao C
Br J Haematol; 2020 May; 189(3):428-437. PubMed ID: 32297671
[TBL] [Abstract][Full Text] [Related]
23. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.
Lee JS; Park S; Jeong HW; Ahn JY; Choi SJ; Lee H; Choi B; Nam SK; Sa M; Kwon JS; Jeong SJ; Lee HK; Park SH; Park SH; Choi JY; Kim SH; Jung I; Shin EC
Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32651212
[TBL] [Abstract][Full Text] [Related]
24. Clinical and pathological investigation of patients with severe COVID-19.
Li S; Jiang L; Li X; Lin F; Wang Y; Li B; Jiang T; An W; Liu S; Liu H; Xu P; Zhao L; Zhang L; Mu J; Wang H; Kang J; Li Y; Huang L; Zhu C; Zhao S; Lu J; Ji J; Zhao J
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427582
[TBL] [Abstract][Full Text] [Related]
25. Single-cell landscape of immunological responses in patients with COVID-19.
Zhang JY; Wang XM; Xing X; Xu Z; Zhang C; Song JW; Fan X; Xia P; Fu JL; Wang SY; Xu RN; Dai XP; Shi L; Huang L; Jiang TJ; Shi M; Zhang Y; Zumla A; Maeurer M; Bai F; Wang FS
Nat Immunol; 2020 Sep; 21(9):1107-1118. PubMed ID: 32788748
[TBL] [Abstract][Full Text] [Related]
26. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
[TBL] [Abstract][Full Text] [Related]
27. Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.
Zhao J; Yang X; Wang C; Song S; Cao K; Wei T; Ji Q; Zheng W; Li J; Zhou X; Liu J
Biomed Pharmacother; 2020 Sep; 129():110436. PubMed ID: 32768938
[TBL] [Abstract][Full Text] [Related]
28. The clinical course and its correlated immune status in COVID-19 pneumonia.
He R; Lu Z; Zhang L; Fan T; Xiong R; Shen X; Feng H; Meng H; Lin W; Jiang W; Geng Q
J Clin Virol; 2020 Jun; 127():104361. PubMed ID: 32344320
[TBL] [Abstract][Full Text] [Related]
29. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis.
Huang W; Berube J; McNamara M; Saksena S; Hartman M; Arshad T; Bornheimer SJ; O'Gorman M
Cytometry A; 2020 Aug; 97(8):772-776. PubMed ID: 32542842
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
31. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience.
Sun Y; Dong Y; Wang L; Xie H; Li B; Chang C; Wang FS
J Autoimmun; 2020 Aug; 112():102473. PubMed ID: 32439209
[TBL] [Abstract][Full Text] [Related]
32. CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients.
Jin M; Shi N; Wang M; Shi C; Lu S; Chang Q; Sha S; Lin Y; Chen Y; Zhou H; Liang K; Huang X; Shi Y; Huang G
Aging (Albany NY); 2020 Oct; 12(20):19867-19879. PubMed ID: 33065551
[TBL] [Abstract][Full Text] [Related]
33. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.
Wang F; Hou H; Wang T; Luo Y; Tang G; Wu S; Zhou H; Sun Z
Travel Med Infect Dis; 2020; 36():101782. PubMed ID: 32526372
[TBL] [Abstract][Full Text] [Related]
34. Association between cytokine profiles and lung injury in COVID-19 pneumonia.
Chen LD; Zhang ZY; Wei XJ; Cai YQ; Yao WZ; Wang MH; Huang QF; Zhang XB
Respir Res; 2020 Jul; 21(1):201. PubMed ID: 32727465
[TBL] [Abstract][Full Text] [Related]
35. A Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes.
Qiu L; Jiao R; Zhang A; Chen X; Ning Q; Fang F; Zeng F; Tian N; Zhang Y; Huang Y; Sun Z; Dhuromsingh M; Li H; Li Y; Xu R; Chen Y; Luo X
Pediatr Infect Dis J; 2020 Jul; 39(7):e87-e90. PubMed ID: 32379199
[TBL] [Abstract][Full Text] [Related]
36. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).
Diao B; Wang C; Tan Y; Chen X; Liu Y; Ning L; Chen L; Li M; Liu Y; Wang G; Yuan Z; Feng Z; Zhang Y; Wu Y; Chen Y
Front Immunol; 2020; 11():827. PubMed ID: 32425950
[No Abstract] [Full Text] [Related]
37. Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19.
Qun S; Wang Y; Chen J; Huang X; Guo H; Lu Z; Wang J; Zheng C; Ma Y; Zhu Y; Xia D; Wang Y; He H; Wang Y; Fei M; Yin Y; Zheng M; Xu Y; Ge W; Hu F; Zhou J
Front Immunol; 2020; 11():2160. PubMed ID: 32983180
[TBL] [Abstract][Full Text] [Related]
38. Reappearance of effector T cells is associated with recovery from COVID-19.
Odak I; Barros-Martins J; Bošnjak B; Stahl K; David S; Wiesner O; Busch M; Hoeper MM; Pink I; Welte T; Cornberg M; Stoll M; Goudeva L; Blasczyk R; Ganser A; Prinz I; Förster R; Koenecke C; Schultze-Florey CR
EBioMedicine; 2020 Jul; 57():102885. PubMed ID: 32650275
[TBL] [Abstract][Full Text] [Related]
39. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
[TBL] [Abstract][Full Text] [Related]
40. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity.
Kang CK; Han GC; Kim M; Kim G; Shin HM; Song KH; Choe PG; Park WB; Kim ES; Kim HB; Kim NJ; Kim HR; Oh MD
Int J Infect Dis; 2020 Aug; 97():313-321. PubMed ID: 32492530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
